GENEVA, July 27 -- ABLINK BIOTECH CO., LTD. filed a patent application (CN2026/072876) for “ANTI-CDH17 ANTIBODY, AND PREPARATION AND USE THEREOF”. With publication no. WO/2026/153436, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/18
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....